- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06165640
Dietary Sodium Intake in Children on Chronic Dialysis (PeDialysis)
Dietary Sodium Intake in Children on Chronic Dialysis: A Collaborative Study With the European Pediatric Dialysis Working Group
Cardiovascular disease is common in patients with end-stage renal disease that began in childhood, and volume overload plays a key role in the development of hypertension, left ventricular hypertrophy (LVH) and alterations. cardiovascular disease in this population. Thus, inter-dialytic weight gain is correlated with blood pressure and left ventricular mass index in children on hemodialysis (HD). Significant inter-dialytic weight gain in dialysis patients is largely due to thirst secondary to salt ingestions: attempts at water restriction without concomitant sodium restriction will probably be in vain. Additionally, sodium overload negatively affects blood pressure and cardiovascular status through various mechanisms unrelated to volume expansion.
Soda extraction by dialysis is often difficult, and sodium control is largely dependent on restricting dietary sodium intake. Some studies in adults have shown that a low sodium diet reduced inter-dialytic weight gain, reduced intra-dialytic complications, improved blood pressure values, and lowered index. left ventricular mass and mortality in dialysis patients.
For children with chronic kidney disease, data from the American Chronic Kidney Disease (CKiD) study show that the median sodium intake in children without dialysis with chronic kidney disease exceeds the maximum recommended intakes for all patients. age groups.
No study to date has investigated the average dietary sodium intake of children on dialysis. And, more importantly, the relationship between dietary sodium intake and cardiovascular morbidity has never been studied in children on dialysis.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ariane ZALOSZYC, MD
- Phone Number: 33 3 88 12 77 42
- Email: ariane.zaloszyc@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67091
- Recruiting
- Service de Pédiatrie 1 - CHU de Strasbourg - France
-
Contact:
- Ariane ZALOSZYC, MD
- Phone Number: 33 3 88 12 77 42
- Email: ariane.zaloszyc@chru-strasbourg.fr
-
Principal Investigator:
- Ariane ZALOSZYC, MD
-
Sub-Investigator:
- Fabio PAGLIALONGLA, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria :
- Minor patient (≥ 3 months and <18 years)
- Under the care of the University Hospitals of Strasbourg
- Having benefited from chronic dialysis (> 3 months)
- Having undergone hemodialysis (HD) or hemodiafiltration (HDF), 3 sessions / week, or automated peritoneal dialysis (PD)
- Subject (and / or his parental authority) not having expressed, after being informed, his opposition to the reuse of his data for the purposes of this research.
Non-Inclusion Criteria :
- Patient or one of the parents who expressed their opposition to participating in the study
- Intensive hemodialysis (HD at home, HD at night, ≥ 4 sessions / week)
- Intercurrent illness or clinical instability (left to the judgment of the physician)
- Non-nephrological diseases causing loss of salt (eg cystic fibrosis, etc.)
- Any physical or psychosocial situation that prevented the 24-hour ambulatory BP measurement from being taken, or poor compliance with the dietetic collection, etc.).
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To determine the average dietary intake of sodium (Na+) in a population of children on chronic dialysis.
Time Frame: Files analysed retrospectively from January 1, 2019 to February 28, 2021 will be examined
|
The average dietary intake of sodium (Na+) is calculated according to the formula: sodium salt content (g) = Sodium (g) × 2.54
|
Files analysed retrospectively from January 1, 2019 to February 28, 2021 will be examined
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 8171
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Dialysis in Children
-
University of ZurichInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedVolemia in Dialysis PatientsSwitzerland
-
Wake Forest University Health SciencesCompletedChronic Toxic Stress | Developmental/ Behavioral Regression in Young ChildrenUnited States
-
Tufts Medical CenterCompletedHypertension in Dialysis Patients | Fluid Overload in Dialysis PatientsUnited States
-
The University of Texas Health Science Center,...Children and Youth with Special Health Care Needs National Research Network...RecruitingChronic Diseases in ChildrenUnited States
-
Umeå UniversityKarolinska Institutet; The Swedish Research Council; Göteborg University; Chalmers... and other collaboratorsActive, not recruitingChronic Diseases in ChildrenSweden
-
Vrije Universiteit BrusselUniversitair Ziekenhuis Brussel; University Ghent; Universitair Ziekenhuis GentTerminatedChronic Diseases in ChildrenBelgium
-
Firat UniversityCompletedChild, Only | Chronic Diseases in ChildrenTurkey
-
Universitair Ziekenhuis BrusselCompletedHospitalization in ChildrenBelgium
-
Astellas Pharma Europe B.V.FibroGenCompletedAnemia in Chronic Kidney Disease in Non-dialysis PatientsSpain, Belarus, Bulgaria, Hungary, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom, Belgium, Georgia, Italy, Colombia, Dominican Republic, Estonia, Greece, Guatemala, Panama, Peru, South Africa, Turkey
-
The University of Texas Health Science Center,...WithdrawnHospitalism in ChildrenUnited States